医療用マイクロチップの世界市場：現状分析と予測（2022年～2028年）

世界の医療用マイクロチップ市場は、医薬品への投資と臨床試験の増加により、約11％の安定した成長が期待されています。さらに、医療用マイクロチップ技術の技術的進歩の高まりが、予測期間中の市場成長に大きく影響すると予想されます。

当レポートでは、世界の医療用マイクロチップ市場について調査分析し、市場概要、セグメント別・地域別の市場分析、市場成長への影響因子、市場動向、競合情勢、主要企業プロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 COVID-19が医療用マイクロチップ市場に与える影響

第6章 医療用マイクロチップ市場収益（2020年～2028年）

第7章 市場洞察：用途別

• ドラッグデリバリー
• ホームモニタリング
• その他

第8章 市場洞察：タイプ別

• 病院
• 研究センター
• その他

第9章 市場洞察：地域別

• 北米
  • 米国
  • カナダ
  • その他北米
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• 世界のその他の地域

第10章 医療用マイクロチップの市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第11章 医療用マイクロチップの市場機会

第12章 医療用マイクロチップの市場動向

第13章 需要サイドと供給サイドの分析

• 需要サイド分析
• 供給サイド分析

第14章 バリューチェーン分析

第15章 価格分析

第16章 戦略的洞察

第17章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第18章 会社概要

• INTROMEDIC
• Otsuka America Pharmaceutical, Inc.
• Applied Microarrays, LLC
• QIAGEN
• Agilent Technologies, Inc.
• Medtronic
• Illumina, Inc.
• BGI
• Macrogen, Inc.
• Bio-Rad Laboratories, Inc.

第19章 免責事項

Medical implant makers incorporate chemicals or medications with the purpose of increasing efficacy and morbidity. Microchips are a novel technology that enables the on-demand delivery of diverse medications over long durations using several reservoirs with discrete pharmacological doses. The global microchips in medicine market is growing at a tremendous rate owing to rising life-threatening diseases, such as specific types of cancers, neurological disorders, and pediatric and rare diseases. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States

The microchips in medicine market is expected to grow at a steady rate of around 11% owing to the increasing growing investment and clinical trials of these medicines. Furthermore, growing technological advancements in microchips in medicine technology is expected to significantly influence the market growth over the forecast period.

Based on application, the market is segmented into drug delivery, home monitoring, and others. Among them, the drug delivery category is to witness higher CAGR during the forecast period owing to the growing demand for enhanced drug delivery systems, which have advantages such as improving the consumption of active pharmaceutical ingredients, reducing dosage frequency, and minimizing adverse/side effects which will further drive the growth of the segment.

On the basis of end-user, the market is categorized into hospitals, research centers, and others. Among these, the hospital held a significant share of the market in 2020. This is mainly due to rising patient administration in hospitals with various neurological diseases, chronic diseases, and rare disorders boosting segmental growth. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.

For a better understanding of the market adoption of the microchips in medicine industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for technology in medicine development for diagnosis purposes, and the presence of several government initiatives in the U.S. and Canada support research in drug development and treatment of various life-threatening diseases.

Some of the major players operating in the market include: INTROMEDIC; Otsuka America Pharmaceutical, Inc.; Applied Microarrays, LLC; QIAGEN; Agilent Technologies, Inc.; Medtronic; Illumina, Inc.; BGI; Macrogen, Inc.; Bio-Rad Laboratories, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Microchips in Medicine Market
• 2.2. Research Methodology of the Microchips in Medicine Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MICROCHIPS IN MEDICINE MARKET

6 MICROCHIPS IN MEDICINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY APPLICATION

• 7.1. Drug Delivery
• 7.2. Home Monitoring
• 7.3. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Hospital
• 8.2. Research Centers
• 8.3. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 MICROCHIPS IN MEDICINE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 MICROCHIPS IN MEDICINE MARKET OPPORTUNITIES

12 MICROCHIPS IN MEDICINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. INTROMEDIC
• 18.2. Otsuka America Pharmaceutical, Inc.
• 18.3. Applied Microarrays, LLC
• 18.4. QIAGEN
• 18.5. Agilent Technologies, Inc.
• 18.6. Medtronic
• 18.7. Illumina, Inc.
• 18.8. BGI
• 18.9. Macrogen, Inc.
• 18.10. Bio-Rad Laboratories, Inc.

19 DISCLAIMER